Song, Z., Su, H., & Zhang, Y. (2016). Patients with ROS1 rearrangement‐positive non‐small‐cell lung cancer benefit from pemetrexed‐based chemotherapy. Cancer Med.
シカゴスタイル引用形Song, Zhengbo, Haiyan Su, , Yiping Zhang. "Patients With ROS1 Rearrangement‐positive Non‐small‐cell Lung Cancer Benefit From Pemetrexed‐based Chemotherapy." Cancer Med 2016.
MLA引用形式Song, Zhengbo, Haiyan Su, , Yiping Zhang. "Patients With ROS1 Rearrangement‐positive Non‐small‐cell Lung Cancer Benefit From Pemetrexed‐based Chemotherapy." Cancer Med 2016.
警告: この引用は必ずしも正確ではありません.